T he adaptive capacity of heart to undergo remodeling after myocardial infarction determines whether the heart will maintain its function at the expense of hypertrophic growth or progress to heart failure. Although the exact biochemical mechanisms responsible for the transition from hemodynamic compensation to decompensation are still unknown, clinical data have shown that circulating level of proinflammatory cytokines, such as tumor necrosis factor-␣ (TNF-␣), are elevated after heart failure. 1,2 TNF-␣ is a pleiotropic intercellular cytokine that is found in almost all cells as part of the injury response repertoire. 3, 4 TNF-␣ binds cell surface receptors TNF-R1 and TNF-R2, which on activation mediate most of the physiological responses of TNF-␣, including negative inotropic effects and apoptosis in cardiac myocytes. [5] [6] [7] Although the precise biological function for stress-induced TNF-␣ expression within the heart still is unknown, the observation that TNF-␣ induces a hypertrophic growth response and apoptosis in cardiac myocytes suggests that it has an important role in myocardial homeostasis.
Previous studies have shown that TNF-␣ is upregulated in the myocardium in response to a variety of forms of cardiac injury, including transient myocardial ischemia and reperfusion. 8, 9 However, it is unclear from existing studies whether TNF-␣ is also expressed in the myocardium chronically after injury, such as acute myocardial infarction. Given the recent observation that TNF-␣ can be produced by a variety of different cell types in the myocardium in response to environmental injury 10, 11 as well as the observation that TNF-␣ can produce left ventricular (LV) dysfunction, 12, 13 cardiomyopathy 14 and pulmonary edema, 15, 16 it has been suggested that persistent cytokine overexpression in the myocardium may contribute to the adverse cardiac remodeling and progressive LV dysfunction that occurs after acute myocardial infarction. Accordingly, to determine whether TNF-␣ is expressed in the myocardium in a chronic model of cardiac injury, we examined both the temporal and spatial expressions of TNF-␣ as well as TNF receptors within the myocardium in a rat chronic model of infarction by coronary artery ligation.
Methods

Creation of Rat Myocardial Infarction Model
A rat model of large myocardial infarction leading to LV dysfunction was used for this study, as previously described by our laboratory. 17 Male Sprague-Dawley rats 12 to 14 weeks old (nϭ54) were randomized to proximal left anterior descending (LAD) ligation (nϭ44) or sham-operated groups (nϭ10). This ligation creates a reproducible large lateral wall infarction. To further ensure uniformity of infarct, only hearts (nϭ20) with infarct of Ն40% of midwall circumference, which were identified and measured by pathological and morphometric methods, were included in the final analysis. The animals were randomized to be killed on days 1, 3, 10, and 35 after coronary ligation, with 5 rats at each of the time points. The heart was removed aseptically and then divided transversely at the level of the papillary muscle. The distal portion was collected for in situ hybridization and immunohistochemical staining studies. A midpapillary slice was taken from the remaining proximal portion of the specimen and divided into blocks representing the midinfarct zone, the peri-infarct zone, and the contralateral noninfarct zone for Northern blot and ELISA analysis. The rats with sham-operated hearts were also killed at the same time points as the ligated group, and heart slices were obtained at the identical level of papillary muscle as were the ligated hearts.
Determination of Gene Expression by Northern Blot Analysis
RNA was isolated from frozen tissue samples that were homogenized and then extracted by the acid guanidinium thiocyanatephenol-chloroform method, as described by Chomczynski and Sacchi. 18 Levels of gene expression were detected by Northern blot analysis. In brief, total RNA (20 g) was denatured in formaldehyde, run in 1.2% agarose-formaldehyde gel, and transferred overnight onto positively charged nylon membrane (Nytran, Schleicher & Schuell Inc). After prehybridization for 4 hours at 42°C, filters were hybridized overnight at 42°C in fresh prehybridization buffer [4ϫSSC, 40% formamide, 1ϫDenhardt's solution, 1% SDS, 100 g/mL denatured salmon sperm DNA (Pharmacia)] containing the denatured 32 P-labeled specific cDNA probes. The filter was sequentially washed for 30 minutes twice with 1ϫSSC at 55°C, followed by washing in 0.2ϫSSC and 0.2% SDS at 60°C until the radioactive background was negligible. TNF-␣ expression was quantitated by scanning densitometry and normalized to the expression of GAPDH. 17 A full-length mouse TNF-␣ cDNA probe in pGEM was a gift from Dr John C. Marshall (Toronto, Ontario). A short-length mouse TNF-␣ cDNA probe of Ϸ700 bp between 375 and 1065 of the coding region was generated by polymerase chain reaction (PCR) and inserted into a TA vector (Invitrogen). The mouse TNF-R1 probe was generated in Dr J. Penninger's laboratory by RT-PCR of the 3Ј-end of TNF-R1 mRNA, and the cDNA was inserted into a pBluescript vector. The TNF-R2 probe was generated by reverse transcription (RT) of total mouse cellular RNA followed by the PCR to generate a specific cDNA fragment. The first cDNA strand was carried out with the use of oligo(dt) (a cDNA synthesis kit from Life Technologies, Gaithersburg, Md). Oligonucleotide primers used to amplify a 676-bp cDNA fragment of TNF-R2 from 780 to 1456 of the coding region are 5Ј-GCTTCCAATTGGTCTGATTG-3Ј and 5Ј-ATCCCTTTGCAGGGTGTTAC-3Ј. All of the cDNA constructs were confirmed by DNA sequence analysis.
Localization of Gene Expression by In Situ Hybridization
Riboprobes for in situ hybridization were generated from linearized templates with T7 or SP6 polymerase. TNF-␣ riboprobes were generated from a 700-kb cloned TNF-␣ cDNA in TA vector as described above. Antisense TNF-␣ riboprobe was synthesized with SP6 RNA polymerase on the EcoRI linearized clone. Sense probe was synthesized by T7 RNA polymerase on the PstI linearized clone. The probes were labeled with a commercially available RNA color kit (Amersham Life Science) according to the manufacturer's specifications.
The tissue sections were hybridized with specific riboprobe in a humidified chamber for 8 hours at 55°C. After washing in TBS (100 mmol/L Tris-HCl, pH 7.5, 400 mmol/L NaCl, 50 mmol/L MgCl 2 ) for 5 minutes with shaking, sections were blocked in 20% NGS and Amersham's blocking agent in TBS at RT for 1 hour. The slides were then incubated for 1 hour with anti-fluorescein alkaline phosphatase conjugate. After the enzymatic reaction, slides were left to develop in the dark for 20 hours at 4°C. The slides were counterstained with 1% neutral red.
Determination of Tissue and Serum TNF-␣ Content by ELISA Assay
The myocardial homogenate was suspended in PBS solution containing protease inhibitors (PMSF 14.9 mmol/L, leupeptin 21 nmol/L, aprotinin 3.1 nmol/L). After centrifugation for 20 minutes at 20 000g, the supernatant, which contained the non-membrane-bound TNF-␣, was collected and stored at Ϫ70°C until use. The pellets were resuspended in PBS containing aprotinin 31 nmol/mL, PMSF 1 mmol/L, 0.1% bacitracin, and 1% Triton X-100. After 1-hour incubation at 4°C, the solubilized proteins were centrifuged for 20 minutes at 20 000g at 4°C to remove the debris. The supernatant contained the solubilized membrane-bound TNF-␣. The protein content of the samples was measured by a Bio-Rad Protein Assay (Bio-Rad Laboratories) with bovine serum albumin as a standard. Quantitative expression of the membrane-bound and nonmembrane-bound TNF-␣ was detected by a sandwich ELISA method with a mouse TNF-␣ DuoSet kit (Genzyme). Serum TNF-␣ was measured similarly.
Localization of TNF-␣ and Receptors by Immunohistochemistry
Frozen sections of 7 mm thick were taken from the basal surface of the distal half of the heart frozen at the time the rats were killed. Sections were incubated with 0.3% H 2 O 2 in methanol for 10 minutes. After washing with H 2 O and PBS with 0.05% Tween-20, slides were incubated in a blocking solution (10% NGS and 3% bovine serum albumin) for 40 minutes. The specific primary antibody or control antibody was added to the section at a concentration of 2 g/mL and incubated for 2 hours at 4°C. The rabbit anti-rat TNF-␣ antibody was purchased from Serotec Ltd. Rabbit anti-mouse TNF-R1/R2 polyclonal antibodies were obtained from Hycult Biotechnology. The slides were washed with TBS-T and incubated with goat anti-rabbit antibody conjugated to Biotin-SP for 1 hour at 4°C, followed by incubation with peroxidase-conjugated streptavidin for 15 minutes. The slides were counterstained with 0.5% methyl green.
Statistical Analysis
All results are expressed as meanϮSEM unless otherwise specified. Statistical significance was estimated among the various groups in TNF-␣ production by 2-way ANOVA. Results were considered to be significant at PϽ0.05.
Results
Temporal and Spatial Changes of TNF-␣ Gene Expression
Changes in expression of the TNF-␣ gene from the infarct, peri-infarct, and contralateral normal zones of rat heart tissue with respect to time are illustrated in Figure 1 . Northern blot analysis demonstrated that TNF-␣ mRNA was consistently detectable in the infarct, peri-infarct, and contralateral zones from infarcted hearts, in contrast to being almost undetectable in normal control heart ( Figure 1A, lane 1) . TNF-␣ mRNA was detected at all 4 time points (days 1, 3, 10, and 35) after ligation operation; however, there was no significant difference among the different days. Most interestingly, the "contralateral normal zone" in the infarcted hearts showed the highest level of TNF-␣ expression, which did not diminish with time after coronary ligation ( Figure 1A, lanes 10 to 13) . The least amount of TNF-␣ mRNA was detected in the peri-infarct zone (lanes 6 to 9). An intermediate amount was detected from the infarct zone (lanes 2 to 5). The pattern was consistently preserved in all groups, regardless of the day the rats were killed.
The quantitative analysis of TNF-␣ expression in relation to GAPDH is illustrated in Figure 1B . The tissue from the sham-operated groups also exhibited weak expression of TNF-␣ mRNA at day 1 after sham manipulation, but by day 3 and afterward, there was no detectable expression of TNF-␣ mRNA (data not shown). Samples were compared with a positive control RNA from a macrophage-like cell line, WEHI-3, stimulated with lipopolysaccharide ( Figure 1A,  lane 14) .
To better define the localization of TNF-␣ gene expression within heart samples, we carried out in situ hybridization at different time points of infarct stages by using TNF-␣ antisense riboprobe (Figure 2 , A through C). Our TNF-␣ riboprobe did not detect TNF-␣ mRNA transcript in normal heart tissue (data not shown). TNF-␣ mRNA in in situ hybridization was identified at day 1 after infarct ligation. High levels of TNF-␣ transcript were observed in day 3 and day 10 ( Figure 2, A and B) and persisted until day 35. The results show that the TNF-␣ mRNA localized to the infarct, peri-infarct, and contralateral zones (Figure 2, A and B) . Within the infarct zone, the TNF-␣ message was identified mainly in the infiltrating cells and endothelial cells of blood vessels. In contrast, in the contralateral noninfarct zone, TNF-␣ mRNA was mainly localized to myocytes ( Figure  2B ). The localization of TNF-␣ production in myocytes was confirmed by Masson's connective tissue staining ( Figure  2C ) by using adjacent sections to differentiate fibroblasts from myocytes.
Temporal and Spatial Changes of TNF-␣ Protein Production
To determine whether change in TNF-␣ mRNA transcript levels results in change in TNF-␣ protein production, a specific rabbit anti-rat TNF-␣ antibody was used for immunostaining. The predominant area of TNF-␣ immunostaining localized to the infarct site and was present at day 1 after Infarct zone represents infarct region of heart. Peri-infarct zone represents margin region between infarction and contralateral heart tissue. Contralateral zone represents normal region of the same infarcted heart. Migration position of 18S is designated by arrowhead. The same blot was rehybridized with GAPDH cDNA probe to control for differences in loading and quality of different RNA preparations. WEHI represents the WEHI-3 cells, which were stimulated with lipopolysaccharide (10 g/mL) for 8 hours, used as positive control. B, Increase over basal level was quantitated by scanning densitometry. Results (meanϮSE) of 3 experiments are shown. Control RNA was extracted from normal rat heart tissue.
ligation. The staining was more intense on day 3 ( Figure 2D ) and day 10 after infarction and persisted within islands of viable myocardium at day 35. Within the infarct zone, TNF-␣ protein was mainly localized to the inflammatory infiltrate, vascular endothelium, and weakly to the cardiomyocyte itself. TNF-␣ protein was detected in the peri-infarct zone with a similar temporal pattern, although with less intensity than the infarct zone. Myocytes in the contralateral noninfarct zone stained for TNF-␣ at all time points after infarction ( Figure 2D ). TNF-␣ protein was undetectable in normal control hearts (data not shown).
Zonal production of TNF-␣ protein was evaluated quantitatively by ELISA with homogenates from different zones of rat infarcted hearts ( Figure 3 ). All tissue sections of the infarcted model showed an increase in TNF-␣ levels similar to the pattern that was observed for TNF-␣ gene expression. The highest levels of TNF-␣ protein were found in the infarct zone, with a significant 8-to 10-fold increase at all 4 different time points when the rats were killed. There is a similar 8-to 10-fold increase of TNF-␣ in the peri-infarct zone on days 1 and 3 but only a 3-fold increase on days 10 and 35. TNF-␣ production exhibited 4-to 5-fold increases in the contralateral zone on days 1 to 10 and returned to normal at day 35. In all animals, whether they underwent LAD ligation or sham operation, serum TNF-␣ was below the detectable limit of the assay (data not shown).
Expression of TNF-␣ Receptor Genes and Immunohistochemistry
Because our results showed that expression of the TNF-␣ gene and protein levels increased in rat infarcted heart model, we analyzed whether there were any corresponding changes in levels of expression of the TNF-␣ receptor genes or their protein levels. A single TNF-R1 mRNA transcript ( Figure  4A ) and TNF-R2 mRNA transcript ( Figure 4C ) were detected in rat heart by Northern blot analysis by using TNF-R1-specific and TNF-R2-specific cDNA probes, respectively. TNF-R1 and TNF-R2 appear to be intrinsically expressed in normal rat hearts ( Figure 4A , lanes 1 and 14; Figure 4C , lane 13). Whereas the levels of TNF-R2 mRNA transcripts in infarcted rat heart did not significantly change compared with the normal control hearts at different postligation time points ( Figure 4C and D) , expression of the TNF-R1 mRNA transcripts in the infarct and peri-infarct zones was upregulated during day 3 and day 10 ( Figure 4A, lanes 3, 4 and 7, 8 ). This increase in TNF-R1 expression subsequently reduced by day 35 ( Figure 4A, lanes 5 and 9) .
Immunohistochemistry results also demonstrated the expression of both TNF-R1 ( Figure 5A ) and TNF-R2 (data not shown) in heart tissues. Expression patterns for both receptors were found to be similar, and the distribution did not change significantly at any time period. Within the infarct zone, there was decreased staining of TNF-R1 and TNF-R2 in the fibroblast tissue. Areas containing endothelial and infiltrating cells showed increased staining for both receptors. The production of TNF-R1/R2 was clearly detected in the myocyte in the contralateral zone by comparing it with the Masson's connective tissue staining ( Figure 5B ).
Discussion
The major new finding of this study, in which we systematically examined the spatial and temporal expression of TNF-␣ and TNF receptors in the myocardium after acute ligation of the LAD coronary artery in rats is that TNF-␣ is Figure 2 . Photomicrographs of in situ hybridization and immunostaining of TNF-␣ in rat heart after LAD ligation. A, Section was taken from rat heart tissue after day 10 LAD ligation. In situ hybridization was performed with short-length TNF-␣ antisense riboprobes (see "Methods" for details), ϫ1. Strong TNF-␣ staining was revealed in infarct and peri-infarct areas. Arrows point to infarct and periinfarct areas. B, Larger magnifications of boxed region shown in A at ϫ120. Arrowheads point to staining of TNF-␣ within myocytes by comparison with adjacent slides of C with Masson's connective tissue stain. D, Immunostaining of rat heart section from day 3 after ligation with anti-rat TNF-␣ antibody, neutral red counterstain, ϫ120. Arrows point to staining of TNF-␣ within myocyte at contralateral zone. Figure 3 . Detection of TNF-␣ from rat infarcted heart tissue by ELISA. TNF-␣ protein was measured in solubilized different zones of rat infarcted heart tissue and normal heart tissue (see "Methods" for details). All results are expressed as means of duplicate determination of 2 experiments ϮSE. *PϽ0.01.
persistently expressed in the myocardium after infarction. Interestingly, the expression of this cytokine was not confined to the infarct zone but was persistently expressed by cardiac myocytes in the contralateral "normal" zone, in which myocardial remodeling was ongoing. We observed that the changes in gene expression were mirrored by concomitant changes in protein production, suggesting that TNF-␣ protein biosynthesis was regulated, at least in part, at the transcriptional level. A second new and important finding of this study was that there was persistent expression of both TNF-R1/R2 receptors after acute ligation of the coronary artery, implying that the signal transduction pathways necessary for TNF-␣ signaling in the heart remain intact as TNF-␣ biosynthesis increases.
Several observations made in this study have important implications in the understanding of cytokine contributions to heart failure. Previously it has been thought that cytokines were mainly produced by inflammatory cells, with the existence of TNF in the myocardium considered mainly passive from the infiltrating inflammatory cells. 19 This was especially suggested by observations of increased TNF-␣ levels in conditions such as myocarditis and Chagas' disease, with a significant known contribution from the inflammatory processes. 20 However, elevated TNF-␣ levels are seen in end-stage heart failure irrespective of the cause of heart failure, and TNF-␣ can be elevated in conditions of hypertrophic cardiomyopathy, in which the inflammatory component is at best minimal. 21 Our study definitely demonstrates that TNF-␣ upregulation occurs very early after myocardial injury and persists in myocytes with time ( Figure 1) . The fact that TNF-␣ gene and protein expression is at a high level in the contralateral zone suggests a potential role of this cytokine in the signaling process leading to myocardial remodeling.
Remodeling is an adaptational process of cardiac myocytes to hemodynamic overload from various causes, such as myocardial infarction. The ability of the heart to undergo remodeling determines the fate of the heart to maintain the function or decompensate. A family of matrix metalloproteinases known to digest the fibrosis collagen matrix has been demonstrated to play an important role in the maintenance of normal function and repairing of the ventricular chamber in response to a superimposed environmental stress. 22 TNF-␣ is known to activate matrix metalloproteinases, including collagenase type 1, stromelysin-1, and gelatinase A and B. 23, 24 TNF-␣ is also known to provoke a modest hypertrophic growth in cardiac myocytes. 6 The observations of this present study that TNF-␣ is produced by myocytes from the contralateral normal zone of myocardium provide further evidence for the role of TNF-␣ in activation of matrix metalloproteinases, which are capable of degrading the components of the extracellular matrix and thereby promoting remodeling of the ventricular chamber in response to myocardial infarction.
Our results demonstrate that TNF-␣ not only is present in the myocardium during the early stages of this ligation model but also persists well into the late stage of the cardiomyopathy phase, when the inflammatory components have already subsided. TNF-␣ has been shown to induce the injury response system, and its downstream signaling events are implicated in the induction of apoptosis. Considering the involvement of TNF-␣ in apoptosis, the continued expression in the late stages of the model has important implications. Recently, programmed cell death has been recognized increasingly as a contributing cause of cardiac myocyte loss in ischemia/reperfusion injury, 25 myocardial infarction, 26 vascular wall remodeling, and long-standing heart failure. [27] [28] [29] Furthermore, TNF-␣ has been shown to contribute to ongoing cell loss in the heart through stimulation of apoptosis. 7 Therefore, the persistence of TNF-␣ into the late stages of the infarct model may be cardiotoxic not only from the negative inotropic effect of TNF-␣ but from TNF-␣-induced apoptosis. The local TNF-␣ production thus should have an important physiological effect on the myocardial remodeling process. Indeed if TNF-␣ is overexpressed, it may contribute to cardiac decompensation.
We were unable to detect TNF-␣ in the serum of any animals, ligated or sham control, suggesting that the increased TNF-␣ level in the myocyte is a local phenomenon. Elevated levels of serum TNF-␣ have been detected in human patients with massive myocardial infarction that eventually led to fatal cardiogenic shock. 30 -32 In our experiments, TNF-␣ was measured only in those animals that survived; these animals had large but not massive infarctions. In massive infarction, it may be that local production of TNF-␣ is sufficiently intense that there is spillover into the systemic circulation accounting for the elevated serum levels. The healed infarction/LV dysfunction model used in our experiment produces clinical heart failure at Ϸ2 months after ligation.
Our results show that rat cardiac tissue expresses both TNF-R1 and TNF-R2, in agreement with previous studies. 33 The presence of the TNF-R1/R2 throughout the period after infarction, including the late stages of postinfarction in the contralateral zone, suggests that the physiological effects of increased TNF-␣ production in the myocardium in the contralateral zone will be transmitted through these receptors to the cells. Many clinical studies have shown that the levels of circulating sTNF-R1 and sTNF-R2 are significantly increased in advanced heart failure. 34, 35 The levels of circulating sTNF-R1 and sTNF-R2 may reflect a generalized shedding of TNF receptors from a variety of different cell types, including the inflammatory cells. Although our study has not clearly identified the mechanism for TNF-R1 upregulation in infarct and peri-infarct zones at day 3 and day 10, a possible explanation is that there are changes in the types of cells present. As we know, many cells infiltrating into the area of tissue injury, such as polymorphonuclear leukocytes, express high levels of TNF-R1. 36 Therefore an elevation in the number of inflammatory cells may contribute to the observed increased level of TNF-R1 mRNA. Immunohistochemistry staining of TNF-R1 in rat heart sample from infarct model. A, Sections from rat heart after day 10 LAD ligation were stained with mouse anti-TNF-R1 antibody, methyl green counterstain, ϫ10. B, Adjacent sections were stained with Masson's connective tissue stain. Arrows point to edge of infarct zone.
